Adhesion molecules, endothelin-1 and lung function in seven population-based cohorts

References

• Bielinski SJ, Pankow JS, Li N, et al. (2008). ICAM1 and VCAM1 polymorphisms, coronary artery calcium, and circulating levels of soluble ICAM-1: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 201:339–44
   PubMed Web of Science ®Google Scholar
• Carratu P, Scoditti C, Maniscalco M, et al. (2008). Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension. BMC Pulm Med 8:20
   PubMedGoogle Scholar
• Celik G, Karabiyikoglu G. (1998). Local and peripheral plasma endothelin-1 in pulmonary hypertension secondary to chronic obstructive pulmonary disease. Respiration 65:289–94
   Google Scholar
• Cella G, Sbarai A, Mazzaro G, et al. (2001). Plasma markers of endothelial dysfunction in chronic obstructive pulmonary disease. Clin Appl Thromb Hemost 7:205–8
   PubMed Web of Science ®Google Scholar
• Chalmers GW, Macleod KJ, Sriram S, et al. (1999). Sputum endothelin-1 is increased in cystic fibrosis and chronic obstructive pulmonary disease. Eur Respir J 13:1288–92
   PubMed Web of Science ®Google Scholar
• Dahl M, Vestbo J, Zacho J, et al. (2011). C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach. Thorax 66:197–204
   PubMed Web of Science ®Google Scholar
• Decramer M, Janssens W, Miravitlles M. (2012). Chronic obstructive pulmonary disease. Lancet 379:1341–51
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Maestrelli P, Roggeri A, et al. (1994). Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am J Respir Crit Care Med 149:803–10
   PubMed Web of Science ®Google Scholar
• Dinh-Xuan AT, Higenbottam TW, Clelland CA, et al. (1991). Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med 324:1539–47
   PubMed Web of Science ®Google Scholar
• Distasi MR, Ley K. (2009). Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability. Trends Immunol 30:547–56
   Google Scholar
• Ebrahim S, Davey Smith G. (2008). Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology? Hum Genet 123:15–33
   Google Scholar
• Elliott P, Chambers JC, Zhang W, et al. (2009). Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302:37–48
   PubMed Web of Science ®Google Scholar
• Ferroni P, Basili S, Martini F, et al. (2000). Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease. J Investig Med 48:21–7
   PubMed Web of Science ®Google Scholar
• Fijnheer R, Frijns CJ, Korteweg J, et al. (1997). The origin of P-selectin as a circulating plasma protein. Thromb Haemost 77:1081–5
   PubMed Web of Science ®Google Scholar
• Glymour MM, Tchetgen EJ, Robins JM. (2012). Credible Mendelian randomization studies: approaches for evaluating the instrumental variable assumptions. Am J Epidemiol 175:332–9
   PubMed Web of Science ®Google Scholar
• Hankinson JL, Kawut SM, Shahar Eet al. (2010). Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults: the multi-ethnic study of atherosclerosis (MESA) lung study. Chest 137:138–45
   PubMed Web of Science ®Google Scholar
• Hankinson JL, Odencrantz JR, Fedan KB. (1999). Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159:179–87
   PubMed Web of Science ®Google Scholar
• Helset E, Lindal S, Olsen R, et al. (1996). Endothelin-1 causes sequential trapping of platelets and neutrophils in pulmonary microcirculation in rats. Am J Physiol 271:L538–46
   PubMed Web of Science ®Google Scholar
• Hogg JC, Chu F, Utokaparch S, et al. (2004). The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350:2645–53
   PubMed Web of Science ®Google Scholar
• Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. (2009). Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 301:2331–9
   PubMed Web of Science ®Google Scholar
• Lawlor DA, Harbord RM, Sterne JA, et al. (2008). Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27:1133–63
   PubMed Web of Science ®Google Scholar
• Linsel-Nitschke P, Gotz A, Erdmann J, et al. (2008). Lifelong reduction of LDL-cholesterol related to a common variant in the LDL-receptor gene decreases the risk of coronary artery disease – a Mendelian randomisation study. PLoS One 3:e2986
   PubMed Web of Science ®Google Scholar
• Musunuru K, Lettre G, Young T, et al. (2010). Candidate gene association resource (CARe): design, methods, and proof of concept. Circ Cardiovasc Genet 3:267–75
   PubMed Web of Science ®Google Scholar
• Noguera A, Busquets X, Sauleda J, et al. (1998). Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158:1664–8
   PubMed Web of Science ®Google Scholar
• Petrache I, Natarajan V, Zhen L, et al. (2005). Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 11:491–8
   PubMed Web of Science ®Google Scholar
• Pigott R, Dillon LP, Hemingway IH, Gearing AJ. (1992). Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 187:584–9
   PubMed Web of Science ®Google Scholar
• Price AL, Patterson NJ, Plenge RM, et al. (2006). Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38:904–9
   PubMed Web of Science ®Google Scholar
• Purcell S, Neale B, Todd-Brown Ket al. (2010). PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–75 . [http://pngu.mgh.harvard.edu/purcell/plink/]
   Google Scholar
• Qi L, Cornelis MC, Kraft P, et al. (2010). Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. Hum Mol Genet 19:1856–62
   Google Scholar
• Redington AE, Springall DR, Ghatei MA, et al. (1995). Endothelin in bronchoalveolar lavage fluid and its relation to airflow obstruction in asthma. Am J Respir Crit Care Med 151:1034–9
   PubMed Web of Science ®Google Scholar
• Riise GC, Larsson S, Lofdahl CG, Andersson BA. (1994). Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis. Eur Respir J 7:1673–7
   PubMed Web of Science ®Google Scholar
• Roland M, Bhowmik A, Sapsford RJ, et al. (2001). Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax 56:30–5
   PubMed Web of Science ®Google Scholar
• Rothman KJ. (1990). No adjustments are needed for multiple comparisons. Epidemiology 1:43–6
   PubMedGoogle Scholar
• Rusznak C, Mills PR, Devalia JL, et al. (2000). Effect of cigarette smoke on the permeability and IL-1beta and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 23:530–6
   PubMed Web of Science ®Google Scholar
• Spiropoulos K, Trakada G, Nikolaou E, et al. (2003). Endothelin-1 levels in the pathophysiology of chronic obstructive pulmonary disease and bronchial asthma. Respir Med 97:983–9
   PubMed Web of Science ®Google Scholar
• Thyagarajan B, Smith LJ, Barr RG, et al. (2009). Association of circulating adhesion molecules with lung function. The CARDIA study. Chest 135:1481–7
   Google Scholar
• Trakada G, Tsourapis S, Marangos M, Spiropoulos K. (2000). Arterial and bronchoalveolar lavage fluid endothelin-1 concentration in asthma. Respir Med 94:992–6
   PubMed Web of Science ®Google Scholar
• van Durme YM, Lahousse L, Verhamme KM, et al. (2011). Mendelian randomization study of interleukin-6 in chronic obstructive pulmonary disease. Respiration 82:530–8
   Google Scholar
• Vittori E, Marini M, Fasoli A, et al. (1992). Increased expression of endothelin in bronchial epithelial cells of asthmatic patients and effect of corticosteroids. Am Rev Respir Dis 146:1320–5
   Google Scholar
• Voelkel NF, Cool CD. (2003). Pulmonary vascular involvement in chronic obstructive pulmonary disease. Eur Respir J Suppl 46:28s–32s
   Google Scholar
• Voight BF, Peloso GM, Orho-Melander M, et al. (2012). Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study. Lancet 380:572–80
   PubMed Web of Science ®Google Scholar
• Walter RE, Wilk JB, Larson MG, et al. (2008). Systemic inflammation and COPD: the Framingham Heart Study. Chest 133:19–25
   PubMed Web of Science ®Google Scholar
• Yamakami T, Taguchi O, Gabazza EC, et al. (1997). Arterial endothelin-1 level in pulmonary emphysema and interstitial lung disease. Relation with pulmonary hypertension during exercise. Eur Respir J 10:2055–60
   PubMed Web of Science ®Google Scholar
• Yanagisawa M, Kurihara H, Kimura S, et al. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–15
   PubMed Web of Science ®Google Scholar
• Zeger SL, Liang KY. (1986). Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121–30
   PubMed Web of Science ®Google Scholar